Atlas Trials

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Clinical trial NCT01162486 · COMPLETED

Trial details

NCT number
NCT01162486
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
TuberculosisTuberculosis, Pulmonary
Start date
2010-04-01
Primary completion
2011-02-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.